IFN-γ is able to restore HLA class I expression and SCLC antigen recognition by CTLs, in vitro, through the induction of different components of the antigen-presentation machinery, among which are TAP1 and TAP2 [11, 12]. This evidence concerns the gene TAP2 and small cell lung carcinoma.